Patents by Inventor Hironori Oosaki

Hironori Oosaki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8058009
    Abstract: The present invention provides target proteins and target genes for bioactive substances such as drugs, and means that enable the development of novel bioactive substances using the same. To be specific, the present invention provides target proteins and target genes for bioactive substances; screening methods for substances capable of regulating bioactivities; bioactivity regulators; a bioactive substance derivative production method; a complex comprising a bioactive substance and a target protein, and a method of producing the complex; and kits comprising a bioactive substance or a salt thereof; determination methods for the onset or risk of onset of a specified disease or condition, determination methods for susceptibility to a bioactive substance, and determination kits used for the determination methods, and the like.
    Type: Grant
    Filed: November 9, 2005
    Date of Patent: November 15, 2011
    Assignee: Reverse Proteomics Research Institute Co., Ltd.
    Inventors: Yorimasa Suwa, Tadakazu Yamauchi, Tsuyoshi Yamada, Hironori Oosaki, Morikazu Kito
  • Publication number: 20080102457
    Abstract: The present invention provides target proteins and target genes for bioactive substances such as drugs, and means that enable the development of novel bioactive substances using the same. To be specific, the present invention provides target proteins and target genes for bioactive substances; screening methods for substances capable of regulating bioactivities; bioactivity regulators; a bioactive substance derivative production method; a complex comprising a bioactive substance and a target protein, and a method of producing the complex; and kits comprising a bioactive substance or a salt thereof; determination methods for the onset or risk of onset of a specified disease or condition, determination methods for susceptibility to a bioactive substance, and determination kits used for the determination methods, and the like.
    Type: Application
    Filed: November 9, 2005
    Publication date: May 1, 2008
    Applicant: Reverse Proteomics Research Institute, Co., Ltd.
    Inventors: Yorimasa Suwa, Tadakazu Yamauchi, Tsuyoshi Yamada, Hironori Oosaki, Morikazu Kito